Enrique Dilone - Net Worth and Insider Trading

Enrique Dilone Net Worth

The estimated net worth of Enrique Dilone is at least $337,261 dollars as of 2024-11-10. Enrique Dilone is the SVP, Technical Operations of Amicus Therapeutics Inc and owns about 30,688 shares of Amicus Therapeutics Inc (FOLD) stock worth over $337,261. Details can be seen in Enrique Dilone's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Enrique Dilone has not made any transactions after 2015-06-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Enrique Dilone

To

Enrique Dilone Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Enrique Dilone owns 1 companies in total, including Amicus Therapeutics Inc (FOLD) .

Click here to see the complete history of Enrique Dilone’s form 4 insider trades.

Insider Ownership Summary of Enrique Dilone

Ticker Comapny Transaction Date Type of Owner
FOLD Amicus Therapeutics Inc 2015-06-19 VP & Technical Operations

Enrique Dilone Latest Holdings Summary

Enrique Dilone currently owns a total of 1 stock. Enrique Dilone owns 30,688 shares of Amicus Therapeutics Inc (FOLD) as of June 19, 2015, with a value of $337,261.

Latest Holdings of Enrique Dilone

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FOLD Amicus Therapeutics Inc 2015-06-19 30,688 10.99 337,261

Holding Weightings of Enrique Dilone


Enrique Dilone Form 4 Trading Tracker

According to the SEC Form 4 filings, Enrique Dilone has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the sale of 14,045 shares on June 19, 2015, which brought Enrique Dilone around $186,237.

Insider Trading History of Enrique Dilone

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Enrique Dilone Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Enrique Dilone Ownership Network

Ownership Network List of Enrique Dilone

No Data

Ownership Network Relation of Enrique Dilone

Insider Network Chart

Enrique Dilone Owned Company Details

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Enrique Dilone is the VP & Technical Operations of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Enrique Dilone made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 232,762 shares made by Bradley L Campbell , a net sale of 333,235 shares made by John F Crowley , and a net sale of 95,000 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 30,401 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 30,401 shares. During the past 18 months, 803,781 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 803,781 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amicus Therapeutics Inc Insider Transactions

No Available Data

Enrique Dilone Mailing Address

Above is the net worth, insider trading, and ownership report for Enrique Dilone. You might contact Enrique Dilone via mailing address: 6 Cedar Brook Drive, Cranbury Nj 08512.